Enibarcimab Granted Fast Track Designation for Septic Shock – Renal and Urology News
The Food and Drug Administration (FDA) has granted Fast Track designation to enibarcimab for the treatment of septic shock. Enibarcimab (formerly
The Food and Drug Administration (FDA) has granted Fast Track designation to enibarcimab for the treatment of septic shock. Enibarcimab (formerly
The findings are from a large prospective, multicenter registry study of men with large prostates treated with Rezūm.
Patients with node-positive prostate cancer are more likely to die from cancer than other causes.
“This data emphasizes the importance of utilizing the EPI test for risk assessment of high-risk prostate cancer in [African American] men,” concluded the authors.
Stephen Williams discusses the evolving role of blue light cystoscopy in detecting non-muscle invasive bladder cancer (NMIBC). The conversation covers its pathophysiology, diagnostic and surveillance…
AI algorithms accurately predict selection of antibiotics for UTI up to three days before culture results are available. #AUA2024
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: A.…
Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative…
The 2024 American Urological Association’s annual meeting is the premiere global gathering of the best and the brightest in the field of Urology. As the…
Results of an exclusive Urology Times survey reveal that more than 70% of respondents said they consider age a relevant factor in the performance of…
The addition of PSMA PET/CT to standard diagnostics may improve patient selection for focal therapy.